Controls

in.vent quality controls are used for internal and external quality control (e.g. for ring tests) and meet the highest standards of medical laboratories. Our control samples are based on real patient samples and are largely made from native human material.

All Quality Controls are infectologically negatively certified with CE-certified test systems.

We produce a variety of standardised and customer-specific controls with and without CE marking.

Controls & Standards

Our Portfolio includes the following Controls:

  • Matrix: true human serum off the clot
  • Levels: 1
  • Parameters: Cardiolipin
  • Stability: 1 year at 2-8 °C
  • Form: lyophilised
  • Matrix: faeces
  • Levels: 3
  • Parameters: Calprotectin
  • Stability: 12 months at 2-8 °C
  • Form: lyophilised
  • Matrix: faeces
  • Levels: 2
  • Parameters: Calprotectin, Elastase
  • Stability: 12 months at 2-8 °C
  • Form: lyophilised
  • Matrix: true human serum off the clot
  • Levels: 8
  • Parameters: CRP
  • Stability: 12 months at 2-8 °C
  • Form: lyophilised
  • Matrix: faeces
  • Levels: 2
  • Parameters: Haemoglobin
  • Stability: 12 months at 2-8 °C
  • Form: lyophilised
  • Matrix: true human serum off the clot
  • Levels: 2
  • Parameters: PSA, fPSA
  • Stability: 2 years at 2-8 °C
  • Form: lyophilised

Certificate

  • Matrix: true human serum off the clot
  • Levels: 4
  • Parameters: PCT
  • Stability: 12 months at 2-8 °C
  • Form: lyophilised
  • Matrix: true human serum off the clot
  • Levels: 2
  • Parameters: Rheumatoid Factor, anti-CCP
  • Stability: 12 months at ≤ -18 °C;  2 months at 2-8 °C
  • Form: liquid
  • Matrix: true human serum off the clot
  • Levels: 2
  • Parameters: SARS-CoV-2 IgG (IgM values on availability)
  • Stability: 6 months at 2-8 °C
  • Form: lyophilised
  • Matrix: true human serum off the clot
  • Levels: 2
  • Parameters: anti-Tg, anti-TPO, TRAb
  • Stability:  2 years at 2-8 °C
  • Form: lyophilised

Es sind zwei Innovationsassistentinnen über den europäischen Sozialfond für den Aufbau folgender Innovationen:

  • Die geplante betriebliche Innovation soll zum Aufbau des Teilbereichs in.vent Clinical Services (ICS) beitragen, um die Dienstleistung des Planens, Durchführens und Dokumentierens von diagnostischen Studien für die diagnostische Industrie, entsprechend der neuesten gesetzlichen Vorgaben anbieten und durchführen zu können.
  • Entwicklung und Implementierung von plattformunabhängigen Testsystemen, und Rohstoffen, spezifischer humaner Biomaterialien sowie Kontrollproben zur Verbesserung der Schilddrüsen-Diagnostik als IVD-Produktpalette.
Qualification measures:

Growing Organisation; Adaption of Qualification to new market demands, project areas and fields of production

To achieve the goal, that invent persist at the international market, qualification for current and new employees were conducted as follows:

  • training in online-marketing,
  • in contract law and
  • in business basics for executive leadership with scientific background.

New employees acquired competences in the fields of:

  • data protection,
  • medical devices advice,
  • internal auditing,
  • performance assessment of in-vitro diagnostics as well as
  • project management

In the field of production, knowledge of macro programming was gained for digitization.

The measures were funded through the European Social Fund and the state of Brandenburg for the period 2019 – 2021.